Ceshi Chen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Venues

Cancer science

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cell death & disease

Cancer research

Shanghai Institute of Materia Medica (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Shanghai Institute of Materia Medica

China

PHD

Nankai University College of Life Sciences

China

BSC

Publications

Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
USP3: Key deubiquitylation enzyme in human diseases. Cancer science 115 (7) (2024)
Zhuo Cheng, Maobo Huang, Wei Li, Lei Hou, Li Jin, Qijin Fan, Linqiang Zhang, Chengbin Li, Li Zeng, Chuanyu Yang, Bin Liang, Fubing Li, Ceshi Chen
HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction. Cell death & disease 15 (1) (2024)
Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
USP3: Key deubiquitylation enzyme in human diseases. Cancer science 115 (7) (2024)
Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
USP3: Key deubiquitylation enzyme in human diseases. Cancer science 115 (7) (2024)
Zhuo Cheng, Maobo Huang, Wei Li, Lei Hou, Li Jin, Qijin Fan, Linqiang Zhang, Chengbin Li, Li Zeng, Chuanyu Yang, Bin Liang, Fubing Li, Ceshi Chen
HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction. Cell death & disease 15 (1) (2024)
Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
USP3: Key deubiquitylation enzyme in human diseases. Cancer science 115 (7) (2024)
Yanjie Kong, Tianlong Lan, Luzhen Wang, Chen Gong, Wenxin Lv, Hailin Zhang, Chengang Zhou, Xiuyun Sun, Wenjing Liu, Haihui Huang, Xin Weng, Chang Cai, Wenfeng Peng, Meng Zhang, Dewei Jiang, Chuanyu Yang, Xia Liu, Yu Rao, Ceshi Chen
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression. Oncogene (2024)
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guo-Hong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer research 84 (14) (2024)
Zhuo Cheng, Maobo Huang, Wei Li, Lei Hou, Li Jin, Qijin Fan, Linqiang Zhang, Chengbin Li, Li Zeng, Chuanyu Yang, Bin Liang, Fubing Li, Ceshi Chen
HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction. Cell death & disease 15 (1) (2024)
Zhuo Cheng, Maobo Huang, Wei Li, Lei Hou, Li Jin, Qijin Fan, Linqiang Zhang, Chengbin Li, Li Zeng, Chuanyu Yang, Bin Liang, Fubing Li, Ceshi Chen
HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction. Cell death & disease 15 (1) (2024)
Ji Ma, Yuqing Gong, Xiaoran Sun, Cheng Liu, Xueying Li, Yi Sun, Decao Yang, Junming He, Mengyuan Wang, Juan Du, Jing Zhang, Weizhi Xu, Tianzhuo Wang, Xiaochun Chi, Yan Tang, Jiagui Song, Yunling Wang, Zongbi Yi, Ceshi Chen, Hong-Quan Zhang, Jun Zhan
Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway. Science advances 10 (27) (2024)
Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
USP3: Key deubiquitylation enzyme in human diseases. Cancer science (2024)
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guo-Hong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer research 84 (14) (2024)
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guo-Hong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
IL1R2 blockade alleviates immunosuppression and potentiates anti-PD-1 efficacy in triple-negative breast cancer. Cancer research (2024)
Ji Ma, Yuqing Gong, Xiaoran Sun, Cheng Liu, Xueying Li, Yi Sun, Decao Yang, Junming He, Mengyuan Wang, Juan Du, Jing Zhang, Weizhi Xu, Tianzhuo Wang, Xiaochun Chi, Yan Tang, Jiagui Song, Yunling Wang, Zongbi Yi, Ceshi Chen, Hong-Quan Zhang, Jun Zhan
Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway. Science advances 10 (27) (2024)
Ji Ma, Yuqing Gong, Xiaoran Sun, Cheng Liu, Xueying Li, Yi Sun, Decao Yang, Junming He, Mengyuan Wang, Juan Du, Jing Zhang, Weizhi Xu, Tianzhuo Wang, Xiaochun Chi, Yan Tang, Jiagui Song, Yunling Wang, Zongbi Yi, Ceshi Chen, Hong-Quan Zhang, Jun Zhan
Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway. Science advances 10 (27) (2024)
Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
USP3: Key deubiquitylation enzyme in human diseases. Cancer science 115 (7) (2024)
Huan Fang, Wenlong Ren, Qiuxia Cui, Huichun Liang, Chuanyu Yang, Wenjing Liu, Xinye Wang, Xue Liu, Yujie Shi, Jing Feng, Ceshi Chen
Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1. eLife 12 (2023)
Junsong Zhao, Junchao Xu, Mingming Wu, Wei Wang, Miaomiao Wang, Leiyan Yang, Huayong Cai, Qiao Xu, Ceshi Chen, Peter E Lobie, Tao Zhu, Xinghua Han
LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2. International journal of molecular sciences 24 (11) (2023)
Zhenbin Wang, Lei Zhang, Bing Li, Jiagui Song, Miao Yu, Jing Zhang, Ceshi Chen, Jun Zhan, Hong-Quan Zhang
Kindlin-2 in myoepithelium controls luminal progenitor commitment to alveoli in mouse mammary gland. Cell death & disease 14 (10) (2023)
Yuanpei Li, Xiaoniu He, Xiao Lu, Zhicheng Gong, Qing Li, Lei Zhang, Ronghui Yang, Chengyi Wu, Jialiang Huang, Jiancheng Ding, Yao-Hui He, Wen Liu, Ceshi Chen, Bin Cao, Dawang Zhou, Yufeng Shi, Juxiang Chen, Chuangui Wang, Shengping Zhang, Jian Zhang, Jing Ye, Han You
METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. Nature communications 13 (1) (2022)
Qiyan Yin, Min Zheng, Qianmei Luo, Dewei Jiang, Huifeng Zhang, Ceshi Chen
YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy. Cells 11 (7) (2022)
Hui Wang, Haibo Xu, Wei Chen, Mei Cheng, Li Zou, Qin Yang, Chi Bun Chan, Hao Zhu, Ceshi Chen, Jianyun Nie, Baowei Jiao
Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor-Stroma Cross-talk. Cancer research 82 (11) (2022)
Wenjing Liu, Min Zheng, Rou Zhang, Qiuyun Jiang, Guangshi Du, Yingying Wu, Chuanyu Yang, Fubing Li, Wei Li, Luzhen Wang, Jiao Wu, Lei Shi, Wenhui Li, Kai Zhang, Zhongmei Zhou, Rong Liu, Yingzheng Gao, Xinwei Huang, Songqing Fan, Xu Zhi, Dewei Jiang, Ceshi Chen
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Rong Liu, Guangxi Yang, Min Bao, Zhongmei Zhou, Xiaoyun Mao, Wenjing Liu, Xiaoyan Jiang, Di Zhu, Xinle Ren, Jian Huang, Ceshi Chen
STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression. Oncogene 41 (16) (2022)
Dewei Jiang, Ting Qiu, Junjiang Peng, Siyuan Li, null Tala, Wenlong Ren, Chuanyu Yang, Yi Wen, Chuan-Huizi Chen, Jian Sun, Yingying Wu, Rong Liu, Jun Zhou, Kongming Wu, Wen Liu, Xiaoyun Mao, Zhongmei Zhou, Ceshi Chen
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer. Cell death and differentiation 29 (6) (2022)
Wenjing Liu, Min Zheng, Rou Zhang, Qiuyun Jiang, Guangshi Du, Yingying Wu, Chuanyu Yang, Fubing Li, Wei Li, Luzhen Wang, Jiao Wu, Lei Shi, Wenhui Li, Kai Zhang, Zhongmei Zhou, Rong Liu, Yingzheng Gao, Xinwei Huang, Songqing Fan, Xu Zhi, Dewei Jiang, Ceshi Chen
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2022)
Wenjing Liu, Min Zheng, Rou Zhang, Qiuyun Jiang, Guangshi Du, Yingying Wu, Chuanyu Yang, Fubing Li, Wei Li, Luzhen Wang, Jiao Wu, Lei Shi, Wenhui Li, Kai Zhang, Zhongmei Zhou, Rong Liu, Yingzheng Gao, Xinwei Huang, Songqing Fan, Xu Zhi, Dewei Jiang, Ceshi Chen
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Wenmin Chen, Lu Zhang, Suling Liu, Ceshi Chen
Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells. Cells 11 (19) (2022)
Wenjing Liu, Min Zheng, Rou Zhang, Qiuyun Jiang, Guangshi Du, Yingying Wu, Chuanyu Yang, Fubing Li, Wei Li, Luzhen Wang, Jiao Wu, Lei Shi, Wenhui Li, Kai Zhang, Zhongmei Zhou, Rong Liu, Yingzheng Gao, Xinwei Huang, Songqing Fan, Xu Zhi, Dewei Jiang, Ceshi Chen
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Fubing Li, Huichun Liang, Hua You, Ji Xiao, Houjun Xia, Xi Chen, Maobo Huang, Zhuo Cheng, Chuanyu Yang, Wenjing Liu, Hailin Zhang, Li Zeng, Yingying Wu, Fei Ge, Zhen Li, Wenhui Zhou, Yi Wen, Zhongmei Zhou, Rong Liu, Dewei Jiang, Ni Xie, Bin Liang, Zhenzhen Liu, Yanjie Kong, Ceshi Chen
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis. Signal transduction and targeted therapy 7 (1) (2022)
Wenjing Liu, Min Zheng, Rou Zhang, Qiuyun Jiang, Guangshi Du, Yingying Wu, Chuanyu Yang, Fubing Li, Wei Li, Luzhen Wang, Jiao Wu, Lei Shi, Wenhui Li, Kai Zhang, Zhongmei Zhou, Rong Liu, Yingzheng Gao, Xinwei Huang, Songqing Fan, Xu Zhi, Dewei Jiang, Ceshi Chen
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Yao Luo, Ceshi Chen
The roles and regulation of the KLF5 transcription factor in cancers. Cancer science 112 (6) (2021)
Yanjie Kong, Zehua Wang, Maobo Huang, Zhongmei Zhou, Yi Li, Huilai Miao, Xing Wan, Jian Huang, Xiaoyun Mao, Ceshi Chen
CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination. International journal of cancer 145 (5) (2019)
Lin Jia, Yundong Shi, Yi Wen, Wei Li, Jing Feng, Ceshi Chen
The roles of TNFAIP2 in cancers and infectious diseases. Journal of cellular and molecular medicine 22 (11) (2018)

Ceshi Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ceshi Chen